RECENT POSTS
FAST MONEY FEATURES
Get in the post game. Respond to our "Question of the Day" right now.
Missed an episode of Fast Money? Watch the lastest show here.
Grab a pencil because school is in session and the Fast Money traders are teaching class.
Download Fast Money onto your MP3 Player.
Grab this all-in-one application and get recaps of the show sent right to your desktop or blog.
Get your game on with Fast Money gear.
Check out our scrapbook. These "pix" are guaranteed winners.
Sign up and receive a recap email every Friday after the show!
Get advanced information about the next Fast Money.
When it comes to preparing for a swine flu outbreak, the top concern for most U.S. business leaders is getting enough vaccine for their employees, according to a new survey from the Business Roundtable.
It will be months before businesses are given the new vaccine, if they get it at all. However, ''companies are on top of the situation,'' Business Roundtable President John Castellani said Wednesday.
Right now companies are waiting to see how big the economic impact will be, and how much extra sick time they might have to grant, Castellani said. That all depends on the severity of the flu.
And companies are stepping up their own efforts to communicate with employees, by e-mailing them updates on sick leave policies and referring them to sources where they can learn more about the flu.
About 225 million doses of the swine flu vaccine are expected to be doled out through this winter.
What’s must you know?
For insights we turned to CNBC’s Pharma reporter Mike Huckman who tells us that there’s some news in the space.
BioCryst [BCRX
Loading...
()
] is moving its antiviral peramivir into late stage studies hoping to prove it's effective in the treatment of hospitalized patients with serious influenza. If approved this drug could be used to treat the most serious cases of swine flu -- patients that are seriously ill and in the hospital.
Meanwhile, Huckman explains that Sanofi-Aventis [SNY
Loading...
()
], AstraZeneca [AZN
Loading...
()
] and Novartis [NVS
Loading...
()
] all say they’ve started shipping their swine flu vaccines while Merck [MRK
Loading...
()
] and Baxter [BAX
Loading...
()
] are still awaiting approval.
What’s the trade?
To me the most interesting name in the space is Gilead [GILD
Loading...
()
] for Tamiflu, says Joe Terranova.
Find out about other important Pharma developments from Huckman. Watch the video now.
- Your First Move For Monday November 23rd
- Burned By JPMorgan, Whirlpool & More
- The Latest Picks That Paid - Friday November 20th
- Web Extra: Defense, Defense
- Pops & Drops: Merck, Monsanto...
- Housing Double Dip?
- Fast Action – Wild, Volatile Week Ahead?
- Bove: Expect Goldman To Increase Dividend Meaningfully
- Bet On Health Care Stalemate?
- Stocks Starting To Crack?
______________________________________________________
Got something to to say? Send us an e-mail at and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send those e-mails to .
Trader disclosure: On Sept. 30th, 2009, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Adami Owns (AGU), (C), (GS), (INTC), (MSFT), (NUE), (BTU); Finerman's Firm Owns (BAC) Preferred Shares, (BAC), (BAC) Call Spreads; Finerman Owns (BAC) Preferred Shares And (BAC); Finerman's Firm And Finerman Own (WFC) Preferred Shares; Finerman's Firm Owns (BKC), (DRI), (MSFT), (YUM); Finerman's Firm Is Short (CAKE), (TLT), (USO), (IJR), (IWM), (SPY), (MDY), (USO), (UNG); Grasso Owns (AAPL), (ABK), (ASTM), (BAC), (C), (COST), (CSCO), (PFE), (PRST), (V), (WMT), (FAZ); Terranova Owns (FCX), (ANR), (SU), (BUCY), (GEX), (POT), (CAM), (MSFT), (AMZN), (GDX), (KCE), (ABT), (SUN); Terranova Owns (XOM) Calls; Terranova Owns (FTO) Calls; Terranova Is Short (GRMN), (ESS), (CCL), (FII), (JWN), (JCI), (WYNN); Terranova Owns March Sugar Futures; Terranova Owns December Copper Futures; Terranova Owns December Crude Oil Futures; Terranova Owns December Gold Futures
GE Is The Parent Company Of CNBC
For Jon Najarian
Jon Najarian Owns (LEAP)
Jon Najarian Owns (SYNA)
Jon Najarian Owns (WFR)
For Joe Terranova:
Terranova Works For (VRTS)
Terranova Is Chief Market Strategist Of Virtus Investment Partners, Ltd.
Virtus Investment Partners Owns More Than 1% Of (CAL)
Virtus Investment Partners Owns More Than 1% Of (DLR)
Virtus Investment Partners Owns More Than 1% Of (EXR)
Virtus Investment Partners Owns More Than 1% Of (IGE)
Virtus Investment Partners Owns More Than 1% Of (DBV)
Virtus Investment Partners Owns More Than 1% Of (SKT)
Virtus Investment Partners Owns More Than 1% Of (TNB)
Virtus Investment Partners Owns More Than 1% Of (UA)
Virtus Investment Partners Owns More Than 1% Of (CLB)
For Steve Grasso:
Stuart Frankel And/Or Partners Own (CUBA)
Stuart Frankel And/Or Partners Own (GERN)
Stuart Frankel And/Or Partners Own (HSPO)
Stuart Frankel And/Or Partners Own (MSFT)
Stuart Frankel And/Or Partners Own (NWS.A)
Stuart Frankel And/Or Partners Own (NXST)
Stuart Frankel And/Or Partners Own (NYX)
Stuart Frankel And/Or Partners Own (PDE)
Stuart Frankel And/Or Partners Own (PRST)
Stuart Frankel And/Or Partners Own (RDC)
Stuart Frankel And/Or Partners Own (ROK)
Stuart Frankel And/Or Partners Own (STWD)
Stuart Frankel And/Or Partners Own (TLM)
Stuart Frankel And/Or Partners Own (VR)
Stuart Frankel And/Or Partners Own (XOM)
Stuart Frankel And/Or Partners Own (XRX)
Stuart Frankel And/Or Partners Own (SDS)
Stuart Frankel And/Or Partners Is Short (QQQQ)
Stuart Frankel And/Or Partners Is Short (CL)
CNBC.com with wires




